We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 333 results
  1. Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety

    The coexistence of cardiovascular disease and erectile dysfunction is widespread, possibly owing to underlying endothelial dysfunction in both...

    Sumon Roy, Robert A. Kloner, ... Ion S. Jovin in Cardiovascular Drugs and Therapy
    Article 15 October 2021
  2. Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease

    Phosphodiesterase (PDE) 4 inhibitors prevent the metabolism of cyclic adenosine monophosphate, thereby reducing inflammation. Inhaled PDE4 inhibitors...

    Dave Singh, Simon Lea, Alexander G. Mathioudakis in Drugs
    Article 03 November 2021
  3. Efficacy of a phosphodiesterase type 5 inhibitor on the pulmonary artery index and postoperative hemodynamics after a Fontan operation

    There have been no reports regarding the influence of a change in the pulmonary artery index before or after a Fontan operation. Moreover, the...

    Takuro Kojima, Koichi Toda, ... Naokata Sumitomo in Heart and Vessels
    Article 18 May 2022
  4. Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis

    Purpose

    Stent-related symptoms are frequent following stent placement for various indications. Use of PDE inhibitors has expanded beyond their...

    Gopal Sharma, Aditya Prakash Sharma, ... Arup K. Mandal in World Journal of Urology
    Article 28 June 2019
  5. Medications mostly associated with priapism events: assessment of the 2015–2020 Food and Drug Administration (FDA) pharmacovigilance database entries

    A range of drugs have a direct role in triggering ischaemic priapism. We aimed at identifying: a) which medications are associated with most...

    Nicolò Schifano, Paolo Capogrosso, ... Andrea Salonia in International Journal of Impotence Research
    Article 21 May 2022
  6. Assessing the Potency of the Novel Tocolytics 2-APB, Glycyl-H-1152, and HC-067047 in Pregnant Human Myometrium

    The intracellular signaling pathways that regulate myometrial contractions can be targeted by drugs for tocolysis. The agents, 2-APB, glycyl-H-1152,...

    Md Reduanul Hossain, Jorge M. Tolosa, ... Jonathan W. Paul in Reproductive Sciences
    Article Open access 17 June 2022
  7. Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review

    Purpose

    We aimed to outline the existing information and the underlying mechanisms of risk of falls associated with the use of urinary antimuscarinics...

    Birkan İlhan, Tuğba Erdoğan, ... Gülistan Bahat in European Geriatric Medicine
    Article 28 May 2023
  8. The effects of epithelial–mesenchymal transitions in COPD induced by cigarette smoke: an update

    Cigarette smoke is a complex aerosol containing a large number of compounds with a variety of toxicity and carcinogenicity. Long-term exposure to...

    **aoshan Su, Wei**g Wu, ... Yiming Zeng in Respiratory Research
    Article Open access 31 August 2022
  9. Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target

    Introduction

    Thioredoxin (Trx) is a secretory protein that acts as an antioxidant, redox regulator, anti-allergic, and anti-inflammatory molecule. It...

    Heena Kansal, Vishal Chopra, ... Siddharth Sharma in Respiratory Research
    Article Open access 24 November 2023
  10. Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome

    Interstitial cystitis/bladder pain syndrome (IC/BPS) is characterized by bladder and/or pelvic pain, increased urinary urgency and frequency and...

    Ashu Mohammad, Mallory A. Laboulaye, ... Amy D. Dobberfuhl in Nature Reviews Urology
    Article 07 February 2024
  11. Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting

    Atopic dermatitis (AD) is a chronic inflammatory skin disorder that affects a substantial number of children and has a significant negative impact on...

    Lawrence F. Eichenfield, Stephen Stripling, ... Lawrence A. Schachner in Pediatric Drugs
    Article Open access 13 June 2022
  12. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions

    Hypertension is a global public health issue and the leading cause of premature death in humans. Despite more than a century of research,...

    Jun Ma, Yanan Li, ... ** Chen in Signal Transduction and Targeted Therapy
    Article Open access 20 April 2023
  13. Skeletal and extraskeletal disorders of biomineralization

    The physiological process of biomineralization is complex and deviation from it leads to a variety of diseases. Progress in the past 10 years has...

    Michael T. Collins, Gemma Marcucci, ... Rajesh V. Thakker in Nature Reviews Endocrinology
    Article 16 May 2022
  14. Potential clinical biomarkers and perspectives in diabetic cardiomyopathy

    Diabetic cardiomyopathy (DCM) is a serious cardiovascular complication and the leading cause of death in diabetic patients. Patients typically do not...

    Jianxin Deng, Fang Yan, ... Dewen Yan in Diabetology & Metabolic Syndrome
    Article Open access 04 March 2023
  15. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines

    Purpose of Review

    Stroke is a leading cause of death and disability worldwide. The annual incidence of new or recurrent stroke is approximately...

    Kunal Bhatia, Lindsey M. Ladd, ... Afshin A. Divani in Current Neurology and Neuroscience Reports
    Article 11 April 2023
  16. Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review

    Coronavirus disease-19 (COVID-19) may result in serious complications involving several organ systems, including myocardial tissue. An exaggerated...

    Christodoulos Papadopoulos, Dimitrios Patoulias, ... Vassilios P. Vassilikos in SN Comprehensive Clinical Medicine
    Article 04 August 2020
  17. A preliminary study of the efficacy of the polyherbal preparation Sao Thong Tai for erectile dysfunction among elderly men: a double-blind, randomized controlled trial

    Background

    The traditional Thai polyherbal formulation “Sao Thong Tai” (STT) contains four medicinal plants, namely Boesenbergia rotunda (L.) Mansf., S...

    Chakariya Lin, Junya Pattraraachachai, ... Surapote Wongyai in Clinical Phytoscience
    Article Open access 21 February 2022
  18. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails

    Phosphodiesterase type 5 inhibitors (PDE5Is) are the drug of choice for medical management of erectile dysfunction (ED). On-demand PDE5Is have an...

    Mary Lee, Roohollah Sharifi in Drugs & Aging
    Article 20 February 2018
  19. Antiplatelet Drugs for Neurointerventions: Part 1 Clinical Pharmacology

    The development of endovascular treatment for intracranial aneurysms has established new techniques such as balloon and stent-assistance, flow...

    Samuel Pearce, Julian T. Maingard, ... Hamed Asadi in Clinical Neuroradiology
    Article 18 May 2020
  20. BPO/LUTS – Aktuelles zur medikamentösen Therapie

    “Lower urinary tract symptoms” (LUTS) are among the most common complaints of urological patients. Benign prostate enlargement represents the most...

    Thomas Burtscher, Jasmin Bektic in Journal für Urologie und Urogynäkologie/Österreich
    Article 24 July 2019
Did you find what you were looking for? Share feedback.